A retrospective comparison of antibiotic regimens for preterm premature rupture of membranes
Rebecca C Pierson1, Sashana S Gordon, David M Haas
1Indiana University School of Medicine and Department of Medicine, Division of Clinical Pharmacology, and Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana.
Objective:
To evaluate whether the use of ampicillin and azithromycin leads to a similar latency period in preterm premature rupture of membranes as ampicillin and erythromycin and whether the substitution of azithromycin for erythromycin effects rates of other outcomes.
Methods:
We performed a retrospective cohort study of women with preterm premature rupture of membranes between 24 and 34 completed weeks of gestation and compared two groups: those who received ampicillin and erythromycin and those who received ampicillin and azithromycin. Primary outcome was length of latency (defined as time from first antibiotic dose to delivery) and secondary outcomes were rates of chorioamnionitis, cesarean delivery, Apgar scores, birth weight, neonatal death, neonatal sepsis, and neonatal respiratory distress syndrome.
Results:
Of 168 women who met inclusion criteria, 75 received ampicillin and erythromycin and 93 received ampicillin and azithromycin. There was no difference in latency between groups: 9.6±13.2 days (erythromycin) compared with 9.4±10.0 (azithromycin) days (P=.40). Secondary outcomes did not differ between groups. We had 80% power to detect a difference of 5 days.
Conclusion:
Among women with preterm premature rupture of membranes between 24 and 34 completed weeks of gestation, substitution of azithromycin for erythromycin in the recommended antibiotic regimen did not affect latency or any other measured maternal or fetal outcomes.
Level Of Evidence:
III.
Insights
Substituting azithromycin for erythromycin in antibiotic regimens for preterm premature rupture of membranes (PPROM) did not alter latency periods or other maternal and fetal outcomes in this study.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Diseases
Background:
- Preterm premature rupture of membranes (PPROM) is a significant obstetric complication.
- Antibiotic therapy is standard for PPROM to prolong latency and improve neonatal outcomes.
- The role of azithromycin versus erythromycin in PPROM management requires evaluation.
Purpose of the Study:
- To compare the latency period in women with PPROM treated with ampicillin and azithromycin versus ampicillin and erythromycin.
- To assess the impact of substituting azithromycin for erythromycin on secondary maternal and neonatal outcomes.
Main Methods:
- Retrospective cohort study of 168 women with PPROM (24-34 weeks gestation).
- Comparison of two antibiotic regimens: ampicillin/erythromycin vs. ampicillin/azithromycin.
- Primary outcome: latency period (time from first antibiotic dose to delivery).
- Secondary outcomes: chorioamnionitis, cesarean delivery, Apgar scores, birth weight, neonatal death, neonatal sepsis, and respiratory distress syndrome.
Main Results:
- No significant difference in latency period between the ampicillin/erythromycin (9.6 days) and ampicillin/azithromycin (9.4 days) groups (P=.40).
- Secondary maternal and neonatal outcomes were similar between the two treatment groups.
- The study was powered to detect a 5-day difference in latency.
Conclusions:
- Substitution of azithromycin for erythromycin in ampicillin-based regimens for PPROM does not affect latency.
- The choice between azithromycin and erythromycin in this context does not appear to influence other key maternal or fetal outcomes.
- Current antibiotic regimens for PPROM can be maintained with either azithromycin or erythromycin without compromising outcomes.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Development of the Oral Microbiota
Acute Pyelonephritis II: Diagnostic Studies and Management


